Boo --
Just this very morning after reading this thread, I discovered a whole raft of studies from the National Institute of Health (NIH) regarding the relationship between cannabis and cancer cure/abatement.
I'll admit I was really surprised. No, more like gobsmacked.
I had no fargin clue that so many
serious studies have been made. If only one in ten are counted, it is still a huge pile of work that has been done regarding cannabis and its effect on cancer in general (and in specifics, too).
I, too, did not think there was anything but wild talk. I now think otherwise. Lookit this --
Specific papers written on cures at NIH:
Brain Cancer
The development of new therapeutic strategies is essential for the management of gliomas, one of the most malignant forms of cancer. We have shown previously that the growth of the rat glioma C6 cell line is inhibited by psychoactive cannabinoids (I. Galve-Roperh et al., Nat. Med., 6: 313-319...
www.ncbi.nlm.nih.gov
Excitotoxicity is a paradigm used to explain the biochemical events in both acute neuronal damage and in slowly progressive, neurodegenerative diseases. Here, we show in a longitudinal magnetic resonance imaging study that Δ9-tetrahydrocannabinol (Δ9-THC), the main active compound in marijuana...
www.jneurosci.org
Recently, cannabinoids (CBs) have been shown to possess antitumor properties. Because the psychoactivity of cannabinoid compounds limits their medicinal usage, we undertook the present study to evaluate the in vitro antiproliferative ability of cannabidiol (CBD), a nonpsychoactive cannabinoid...
jpet.aspetjournals.org
--------------------------------------------------------------
Mouth and Throat Cancer
These results show the cannabinoids are potent inhibitors of Tu183 cellular respiration and are toxic to this highly malignant tumor.
www.ncbi.nlm.nih.gov
--------------------------------------------------------------
Breast Cancer
Invasion and metastasis of aggressive breast cancer cells are the final and fatal steps during cancer progression. Clinically, there are still limited therapeutic interventions for aggressive and metastatic breast cancers available. Therefore, effective, targeted, and non-toxic therapies are...
www.ncbi.nlm.nih.gov
Invasion and metastasis of aggressive breast cancer cells is the final and fatal step during cancer progression, and is the least understood genetically. Clinically, there are still limited therapeutic interventions for aggressive and metastatic breast cancers available. Clearly, effective and...
www.ncbi.nlm.nih.gov
This study provides novel insights into the crosstalk between CB(2) and CXCR4/CXCL12-signaling pathways in the modulation of breast tumor growth and metastasis. Furthermore, these studies indicate that CB(2) receptors could be used for developing innovative therapeutic strategies against breast...
www.ncbi.nlm.nih.gov
jpet.aspetjournals.org
Background ErbB2-positive breast cancer is characterized by highly aggressive phenotypes and reduced responsiveness to standard therapies. Although specific ErbB2-targeted therapies have been designed, only a small percentage of patients respond to these treatments and most of them eventually...
www.molecular-cancer.com
Breast cancer is a very common disease that affects approximately 1 in 10 women at some point in their lives. Importantly, breast cancer cannot be considered a single disease as it is characterized by distinct pathological and molecular subtypes that are treated with different therapies and have...
www.ncbi.nlm.nih.gov
-----------------------------------------------------------------
Lung Cancer
Cannabinoids inhibit cancer cell invasion via increasing tissue inhibitor of matrix metalloproteinases-1 (TIMP-1). This study investigates the role of intercellular adhesion molecule-1 (ICAM-1) within this action. In the lung cancer cell lines A549, H358, and H460, cannabidiol (CBD; 0.001-3 μM)...
www.ncbi.nlm.nih.gov
Non-small cell lung cancer (NSCLC) is the leading cause of cancer deaths worldwide; however, only limited therapeutic treatments are available. Hence, we investigated the role of cannabinoid receptors, CB1 and CB2, as novel therapeutic targets against NSCLC. We observed expression of CB1 (24%)...
www.ncbi.nlm.nih.gov
---------------------------------------------------------------------
Uterine, Testicular, and Pancreatic Cancers
Cannabis has been used medicinally for millennia, but has not been approved by the U.S. Food and Drug Administration to treat any medical condition. Cannabinoids are the components in cannabis; some are commercially available to treat symptoms. Get detailed information in this clinician summary.
www.cancer.gov
---------------------------------------------------------------------
Prostate Cancer
The potent anti-proliferative and cytotoxic effects of ANA on metastatic prostatic cancer cells might provide basis for the design of new therapeutic agents for effective treatment of recurrent and invasive prostatic cancers.
www.ncbi.nlm.nih.gov
Prostate cancer is a global public health problem, and it is the most common cancer in American men and the second cause for cancer-related death. Experimental evidence shows that prostate tissue possesses cannabinoid receptors and their stimulation results ...
www.ncbi.nlm.nih.gov
These data support the clinical testing of CBD against prostate carcinoma.
www.ncbi.nlm.nih.gov
------------------------------------------------------------------------------
Colorectal Cancer
Colon cancer affects millions of individuals in Western countries. Cannabidiol, a safe and non-psychotropic ingredient of Cannabis sativa, exerts pharmacological actions (antioxidant and intestinal antinflammatory) and mechanisms (inhibition of endocannabinoid enzymatic degradation) potentially...
www.ncbi.nlm.nih.gov
-----------------------------------------------------------------------------
Ovarian Cancer
-----------------------------------------------------------------------------
Blood Cancer
In the current study, we examined whether ligation of CB2 receptors would lead to induction of apoptosis in tumors of immune origin and whether CB2 agonist could be used to treat such cancers. Exposure of murine tumors EL-4, LSA, and P815 to delta-9-tetrahydrocannabinol (THC) in vitro led to a...
www.ncbi.nlm.nih.gov
Plant-derived cannabinoids, including Delta9-tetrahydrocannabinol (THC), induce apoptosis in leukemic cells, although the precise mechanism remains unclear. In the current study, we investigated the effect of THC on the upstream and downstream events that modulate the extracellular...
www.ncbi.nlm.nih.gov
We have recently shown that cannabinoids induce growth inhibition and apoptosis in mantle cell lymphoma (MCL), a malignant B-cell lymphoma that expresses high levels of cannabinoid receptor types 1 and 2 (CB1 and CB2). In the current study, the role of each receptor and the signal transduction...
molpharm.aspetjournals.org
-----------------------------------------------------------------------------
Skin Cancer
Nonmelanoma skin cancer is one of the most common malignancies in humans. Different therapeutic strategies for the treatment of these tumors are currently being investigated. Given the growth-inhibiting effects of cannabinoids on gliomas and the wide tissue distribution of the two subtypes of...
www.ncbi.nlm.nih.gov
----------------------------------------------------------------------------
Bladder Cancer
http://www.medscape.com/viewarticle/803983 (Sign-up required to view study)
----------------------------------------------------------------------------
Cancer in General
Inhibition of tumor angiogenesis by cannabinoids - PubMed
Cannabinoids inhibit tumor angiogenesis in mice, but the mechanism of their antiangiogenic action is still unknown. Because the vascular endothelial growth factor (VEGF) pathway plays a critical role in tumor angiogenesis, here we studied whether cannabinoids affect it. As a first approach, cDNA...
www.ncbi.nlm.nih.gov
Cannabinoids inhibit tumor angiogenesis in mice, but the mechanism of their antiangiogenic action is still unknown. Because the vascular endothelial growth factor (VEGF) pathway plays a critical role in tumor angiogenesis, here we studied whether cannabinoids affect it. As a first approach, cDNA...
www.ncbi.nlm.nih.gov